VIRAL TRANSMISSION AND TROPISM

TAG: GS 3: SCIENCE AND TECHNOLOGY

THE CONTEXT: Recent research conducted at the Institute of Molecular Virology at Ulm University Medical Centre, Germany, sheds light on a novel defense mechanism employed by the human body to inhibit viral transmission via non-conventional routes.

EXPLANATION:

  • Published in Nature Microbiology, the study reveals the role of extracellular vesicles in bodily fluids, such as saliva and semen, in inhibiting viral infection.

Extracellular Vesicles as Defense Agents

  • Extracellular vesicles, small structures enclosed by fat, play a crucial role in intercellular communication and substance transport.
  • The researchers found that these vesicles are abundant in saliva and semen and contain PS proteins on their surfaces, similar to those exploited by viruses for entry.
  • Through a series of experiments, they demonstrated that these vesicles compete with viruses for entry receptors, thereby impeding viral infection.

Implications of the Discovery

  • The study’s findings extend beyond Zika virus to encompass other viruses that utilize the PS receptor for entry, including dengue, chikungunya, West Nile, ebola, and vesicular stomatitis viruses.
  • Importantly, viruses that do not utilize the PS receptor, such as HIV and SARS-CoV-2, remain unaffected by the presence of extracellular vesicles.
  • This discovery represents a significant advancement in our understanding of host defense mechanisms against viral infections.

Viruses:

  • Viruses, such as Zika, dengue, and chikungunya, are adept at transmitting themselves from host to host, a crucial aspect of their life cycle.
  • Achieving successful transmission is a complex interplay between the virus and the host’s immune system.
  • For a virus to successfully infect a new host, it must first gain access to target cells, a process known as tropism.
  • Tropism is driven by specific interactions between viral surface proteins and receptors on host cells.
  • These receptors are typically highly selective, dictating which cells the virus can infect.
  • For instance, HIV targets cells expressing the CD4 protein, while SARS-CoV-2 uses the ACE2 receptor for entry.
  • One such receptor of interest is phosphatidyl serine (PS), typically expressed by dying cells in the body.
  • PS acts as a signal for immune cells to initiate the clearance of these dying cells.
  • However, viruses have evolved a strategy known as apoptotic mimicry, wherein they express PS on their own surfaces.
  • By doing so, viruses can exploit the PS pathway to infect host cells, effectively hijacking the immune response for their benefit.

Challenges in Studying Viral Transmission

  • Studying viral transmission presents significant challenges, particularly when viruses utilize receptors like PS for entry.
  • These receptors are often expressed by various cell types, complicating the understanding of transmission routes.
  • Additionally, the mere presence of a virus in a bodily fluid does not guarantee transmission through that route.
  • For example, although Zika virus can be detected in saliva, semen, and breast milk, it primarily spreads via mosquitoes rather than orally or sexually.

Future Directions and Speculations

  • While the therapeutic implications of this discovery are yet to be fully realized, it opens up new avenues for research into potential antiviral strategies.
  • Furthermore, the study raises intriguing questions about the evolutionary dynamics between viruses and their hosts.
  • The notion that PS-containing vesicles in humans may have influenced the evolution of mosquito-borne viruses presents a thought-provoking avenue for further investigation.

SOURCE: https://www.thehindu.com/sci-tech/science/new-type-of-host-defence-against-zika-dengue-infections-revealed/article68097589.ece/amp/

Spread the Word